Publications by authors named "Tapio Utriainen"

Claim this Profile
T
Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer.
Karim Fizazi, Alice Bernard-Tessier, Guilhem Roubaud, Tapio Utriainen, Philippe Barthélémy

NEJM Evid· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radium-223 dichloride treatment in metastatic castration-resistant prostate cancer in Finland: A real-world evidence multicenter study.
Anniina Hyväkkä, Okko-Sakari Kääriäinen, Tapio Utriainen, Eliisa Löyttyniemi, Kalle Mattila

Cancer Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis.
Mari Karimaa, Reetta Riikonen, Henna Kettunen, Päivi Taavitsainen, Meri Ramela, Tapio Utriainen

Mol Cancer Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Matthew R Smith, Maha Hussain, Fred Saad, Karim Fizazi, Cora N Sternberg, Tapio Utriainen

N Engl J Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biweekly Cabazitaxel Is a Safe Treatment Option for Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients After Docetaxel - A Final Analysis of the Prosty II Trial.
Pirkko-Liisa Kellokumpu-Lehtinen, Timo Marttila, Antti Jekunen, Petteri Hervonen, Katariina Klintrup, Tapio Utriainen

Anticancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High frequency of osteonecrosis of the jaw among denosumab-treated prostate cancer patients.
Leena Vehmanen, Juho Suojanen, Risto Kontio, Tapio Utriainen, Carl Blomqvist

Acta Oncol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pazopanib after sunitinib failure in patients with metastatic renal cell carcinoma.
Juhana Rautiola, Tapio Utriainen, Katriina Peltola, Heikki Joensuu, Petri Bono

Acta Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma.
Petri Bono, Juhana Rautiola, Tapio Utriainen, Heikki Joensuu

Acta Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial.
Heikki Joensuu, Petri Bono, Vesa Kataja, Tuomo Alanko, Riitta Kokko, Tapio Utriainen

J Clin Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.
Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Petri Bono, Tuomo Alanko, Vesa Kataja, Tapio Utriainen

N Engl J Med· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography.
Meri Utriainen, Liisa Metsähonkala, Toivo T Salmi, Tapio Utriainen, Hannu Kalimo

Cancer· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis